Ronald M. Kurtz Md serves as Executive at RxSight, Inc., where they oversee executive responsibilities. Since joining the company, Ronald M. Kurtz Md has executed 12 insider transactions totaling $9.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 9, 2024 involved exercising options for 7,650 shares valued at $115.4K.
Ronald M. Kurtz Md currently holds 61,150 shares of RxSight, Inc. (RXST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald M. Kurtz Md has been a net seller of RXST stock. They have purchased $2.1M and sold $7.7M worth of shares.
Ronald M. Kurtz Md's most recent insider trade was on Aug 9, 2024, when they sold 7,650 shares at $15.08 per share.
Get notified when new Form 4 filings are submitted
| 2,300 |
| $4.34 |
| Discretionary |
| Jul 11, 2024 | RXST | $203.6K | Option Exercise | 13,500 | $15.08 | Discretionary |
| May 3, 2024 | RXST | $2.4M | Sale | 40,000 | $60.15 | Planned |
| Jan 8, 2024 | RXST | $1.4M | Sale | 31,250 | $45.00 | Planned |
| Jan 8, 2024 | RXST | $1.4M | Sale | 31,250 | $43.50 | Planned |
| Dec 27, 2023 | RXST | $924.5K | Sale | 22,500 | $41.09 | Planned |
| Dec 14, 2023 | RXST | $800.2K | Sale | 20,000 | $40.01 | Planned |
| Dec 14, 2023 | RXST | $788.0K | Sale | 20,000 | $39.40 | Planned |
| Feb 10, 2023 | RXST | $500.0K | Award | 40,000 | $12.50 | Discretionary |
| Aug 5, 2021 | RXST | $50.4K | Purchase | 3,638 | $13.85 | Discretionary |
| Aug 3, 2021 | RXST | $2.0M | Purchase | 125,000 | $16.00 | Discretionary |